Nivolumab Versus Docetaxel in a Predominantly Chinese Patient Population With Previously Treated Advanced NSCLC: CheckMate 078 Randomized Phase III Clinical Trial.
| Autor: | Wu, Yi-Long, Lu, Shun, Cheng, Ying, Zhou, Caicun, Wang, Jie, Mok, Tony, Zhang, Li, Tu, Hai-Yan, Wu, Lin, Feng, Jifeng, Zhang, Yiping, Luft, Alexander Valerievich, Zhou, Jianying, Ma, Zhiyong, Lu, You, Hu, Chengping, Shi, Yuankai, Baudelet, Christine, Cai, Junliang, Chang, Jianhua |
|---|---|
| Zdroj: | Journal of Thoracic Oncology; May2019, Vol. 14 Issue 5, p867-875, 9p |
| Databáze: | Complementary Index |
| Externí odkaz: |
|